Photobiomodulation Therapy Delays Dry AMD Progression

Multiwavelength PBM approach shows visual acuity and disease morphology benefits.

By Samuel Asanad, MD, David S. Boyer, MD

Complement Inhibition for Geographic Atrophy

Inhibition of the complement system offers a promising approach to slow GA progression, but challenges remain.

By Aumer Shughoury, MD, Thomas A. Ciulla, MD, MBA

Refining a Deep Learning Model’s Ability to Identify GA Area

The GEODE study evaluated the use of 3D volumetric OCT data to accurately segment the area.

By Simrat K. Sodhi, MSc, MB BChir (Cantab), Hasenin Al-Khersan, MD, David S. Boyer, MD, et al.

Functional Outcomes of Current Dry AMD Therapies

Beyond GA lesion growth, consider functional outcomes to provide informed, comprehensive care.

By Kaitlyn Cheng, BA, Raziyeh Mahmoudzadeh, MD, Jessica D. Randolph, MD

Upfront: What Type of Learner Are You?

By Diana V. Do, MD

New Product Applications: Introducing the Cirrus 6000

The newest generation of Zeiss’s OCT device allows for precise analysis, faster throughput, and smarter decision-making.

By Karen Appold, contributing writer

Coding: Injection Diagnosis Code Challenges

To ensure payment for every drug administered in the practice, knowing and following the payer’s rules is imperative.

By Elizabeth Cifers, MBA, MSW, CHC, CPC

Clinical Trial Update March 2025

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.